Bill & Melinda Gates Foundation

Touchlight secures $2.4m to prove pandemic potential of synthetic DNA vector

29-Nov-2022 By Jane Byrne

Touchlight has secured a grant from the Bill & Melinda Gates Foundation for a research program aimed at demonstrating that its enzymatically produced novel DNA format can support a rapid, scalable, durable, and thermostable vaccine solution for future...

Vir Biotechnology and Bill & Melinda Gates Foundation to develop vaccinal antibody tech for tackling HIV and malaria

17-Jan-2022 By Rachel Arthur

Vir Biotechnology and the Bill & Melinda Gates Foundation have partnered up to develop broadly neutralizing antibodies designed to provide a ‘vaccinal effect’ for the treatment of HIV and prevention of malaria.

Tuberculosis vaccine development in the spotlight as WHO warns TB deaths have increased

08-Nov-2021 By Rachel Arthur

The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and - for the first time in over a decade - TB deaths have increased. Research breakthroughs – such as new vaccines – are needed to rapidly reduce the number of new cases...

Gates Foundation gives Dynavax COVID-19 grant to scale up adjuvant production

17-Aug-2020 By Nick Taylor

Dynavax gets Bill & Melinda Gates Foundation funding to scale up production of adjuvant for use in COVID-19 vaccines.

Gates Foundation commits $150m to make COVID-19 vaccines for $3 a dose

11-Aug-2020 By Nick Taylor

The Bill & Melinda Gates Foundation provides $150 million for production of $3 doses of COVID-19 vaccines.

Gavi backed with $8.8bn to support immunization plans

17-Jun-2020 By Ben Hargreaves

The Vaccine Alliance given funds to support the immunization of 300 million children and to develop measures against COVID-19.

Gates Foundation in ‘unprecedented’ coronavirus partnership with industry

26-Mar-2020 By Ben Hargreaves

‘Collective action is critical,’ says Novartis CEO on industry partnership with Gates Foundation to accelerate treatments for COVID-19.

Gates Foundation, Wellcome and Mastercard partner to combat coronavirus

12-Mar-2020 By Ben Hargreaves

The three organizations set up the COVID-19 Therapeutics Accelerator, backing the initiative with $125m.

‘Miniaturized’ vaccine production line to be adapted for M&R program

25-Jun-2019 By Maggie Lynch

After a grant from the Bill & Melinda Gates Foundation, Univercells will adapt its low-footprint, cabinet-contained vaccine production line to create affordable measles and rubella vaccinations.